Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Diabetes in Developing Countries
Literature
1.
Palumbo PJ, Melton III LJ. In: National Diabetes Data Group, editor. Peripheral vascular disease and diabetes. Diabetes in America. Washington: DHHS; 1995. p. 401–7.
2.
Armstrong DG, Lavery LA. Diabetic foot ulcers: prevention, diagnosis and classification. Am Fam Physician. 1998;57:1337–8.
3.
Larsson J, Apelqvist J, Agardh CD, et al. Decreasing incidence of major amputation in diabetic patients: a consequences of a multidisciplinary foot care approach? Diabet Med. 1995;12:770–6.PubMedCrossRef
4.
World Health Report 1999, Making a difference, Report of the Director General WHO 1999.
5.
WHO. Prevention and control of diabetes mellitus, report of an Intercountry workshop, Dhaka, Bangladesh, 27–30 April 1998, SEA/NCD/40, 1998.
6.
Wang C, Schwaitzberg S, Berliner E, Zarin DA, Lau J. Hyperbaric oxygen for treating wounds: a systemic review of the literature. Arch Surg. 2003;138:272.
Metadata
Title
Hyperbaric oxygen therapy in diabetic foot: a study in Asian–Indians
Authors
Chandra Shekhar
M. P. Arora
Mridula Pawar
Madhu Sinha
Jugal Kishore
Publication date
01-12-2014
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 4/2014
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-014-0193-z

Other articles of this Issue 4/2014

International Journal of Diabetes in Developing Countries 4/2014 Go to the issue

Review Article

Ethical considerations of Ramadan fasting in diabetic patients according to Shiite school of thought

Letter to Editor

Acromegaly presenting as Diabetic ketoacidosis

Original Article

A correlation study of CVD risk factors in Type 2 diabetics of Western Rajasthan

Original Article

Endogenous insulin secretion ability in meal tolerance test correlated with body mass index (BMI) in Japanese type 2 diabetes patients

Letter to Editor

Knowledge and awareness of diabetes amongst diabetes patients in Wardha region

Original Article

A study on prevalence of abnormal glucose tolerance and correlation of insulin resistance with dyslipidemia in South-Indian women with polycystic ovary syndrome
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits